FLUTICASONE PROPIONATE

Fluticasone Propionate Adverse Events Reported to the FDA Over Time

How are Fluticasone Propionate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Fluticasone Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Fluticasone Propionate is flagged as the suspect drug causing the adverse event.

Most Common Fluticasone Propionate Adverse Events Reported to the FDA

What are the most common Fluticasone Propionate adverse events reported to the FDA?

Drug Ineffective	4998 (6.36%)
Dyspnoea	3725 (4.74%)
Product Quality Issue	2698 (3.43%)
Asthma	2605 (3.31%)
Dysphonia	2030 (2.58%)
Cough	2015 (2.56%)
Pneumonia	1097 (1.4%)
Headache	949 (1.21%)
Death	801 (1.02%)
Dizziness	779 (.99%)
Chest Discomfort	766 (.97%)
	Show More
Wheezing	761 (.97%)
Candidiasis	743 (.95%)
Chest Pain	627 (.8%)
Malaise	574 (.73%)
Throat Irritation	573 (.73%)
Epistaxis	555 (.71%)
Ill-defined Disorder	537 (.68%)
Fatigue	534 (.68%)
Weight Increased	517 (.66%)
Nausea	474 (.6%)
Cataract	465 (.59%)
Tremor	454 (.58%)
Chronic Obstructive Pulmonary Disea...	445 (.57%)
Heart Rate Increased	442 (.56%)
Rash	438 (.56%)
Overdose	437 (.56%)
Dry Mouth	435 (.55%)
Drug Administration Error	425 (.54%)
Dysgeusia	415 (.53%)
Aphonia	414 (.53%)
Insomnia	407 (.52%)
Palpitations	396 (.5%)
Bronchitis	392 (.5%)
Oropharyngeal Pain	392 (.5%)
Adverse Event	387 (.49%)
Muscle Spasms	387 (.49%)
Vision Blurred	372 (.47%)
Asthenia	352 (.45%)
Condition Aggravated	352 (.45%)
Pain	339 (.43%)
Feeling Abnormal	337 (.43%)
Hypersensitivity	336 (.43%)
Oral Candidiasis	335 (.43%)
Pruritus	319 (.41%)
Blood Pressure Increased	318 (.4%)
Vomiting	318 (.4%)
Anxiety	312 (.4%)
Pyrexia	272 (.35%)
Nervousness	264 (.34%)
Productive Cough	255 (.32%)
Nasopharyngitis	246 (.31%)
Arthralgia	244 (.31%)
Choking	243 (.31%)
Urticaria	241 (.31%)
Therapeutic Response Decreased	240 (.31%)
Anosmia	230 (.29%)
Myalgia	226 (.29%)
Sinusitis	226 (.29%)
Inhalation Therapy	225 (.29%)
Respiratory Disorder	222 (.28%)
Ageusia	220 (.28%)
Increased Upper Airway Secretion	217 (.28%)
Medication Error	208 (.26%)
Myocardial Infarction	205 (.26%)
Pain In Extremity	203 (.26%)
Drug Interaction	202 (.26%)
Dysphagia	201 (.26%)
Glossodynia	194 (.25%)
Fall	192 (.24%)
Rhinorrhoea	189 (.24%)
Diarrhoea	188 (.24%)
Oedema Peripheral	187 (.24%)
Stomatitis	184 (.23%)
Hypertension	183 (.23%)
Laryngitis	183 (.23%)
Nasal Congestion	182 (.23%)
Paraesthesia	181 (.23%)
Hypoaesthesia	180 (.23%)
Loss Of Consciousness	175 (.22%)
Lung Disorder	175 (.22%)
Throat Tightness	175 (.22%)
Visual Acuity Reduced	175 (.22%)
Drug Exposure During Pregnancy	174 (.22%)
Oral Pain	174 (.22%)
Dry Throat	172 (.22%)
Back Pain	171 (.22%)
Convulsion	167 (.21%)
Erythema	165 (.21%)
Cardiac Disorder	163 (.21%)
Depression	162 (.21%)
Weight Decreased	162 (.21%)
Blood Glucose Increased	159 (.2%)
Swelling Face	159 (.2%)
Nasal Discomfort	157 (.2%)
Abdominal Pain Upper	154 (.2%)
Burning Sensation	148 (.19%)
Cerebrovascular Accident	147 (.19%)
Expired Drug Administered	147 (.19%)
Feeling Jittery	147 (.19%)
Speech Disorder	143 (.18%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Fluticasone Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fluticasone Propionate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Fluticasone Propionate

What are the most common Fluticasone Propionate adverse events reported to the FDA?

Respiratory	12203 (15.52%)
Therapeutic And Nontherapeutic Effe...	6354 (8.08%)
Bronchial Disorders	4165 (5.3%)
Neurological	3639 (4.63%)
Infections - Pathogen Unspecified	3166 (4.03%)
Product Quality Issues	2833 (3.6%)
Epidermal And Dermal Conditions	1787 (2.27%)
Gastrointestinal Signs	1786 (2.27%)
Medication Errors	1695 (2.16%)
Fungal Infectious	1581 (2.01%)
Upper Respiratory Tract Disorders	1531 (1.95%)
	Show More
Headaches	1089 (1.39%)
Oral Soft Tissue Conditions	1084 (1.38%)
Cardiac And Vascular Investigations	1039 (1.32%)
Vision	949 (1.21%)
Anxiety Disorders	934 (1.19%)
Muscle	888 (1.13%)
Fatal Outcomes	838 (1.07%)
Musculoskeletal And Connective Tiss...	784 (1%)
Physical Examination Topics	784 (1%)
Injuries	757 (.96%)
Cardiac Arrhythmias	739 (.94%)
Movement Disorders	715 (.91%)
Tongue Conditions	678 (.86%)
Sleep Disorders	663 (.84%)
Cardiac Disorder Signs	625 (.8%)
Dental And Gingival Conditions	567 (.72%)
Allergic Conditions	561 (.71%)
Joint	517 (.66%)
Eye	503 (.64%)
Anterior Eye Structural Change, Dep...	501 (.64%)
Salivary Gland Conditions	487 (.62%)
Gastrointestinal Motility And Defec...	461 (.59%)
Bone Disorders	432 (.55%)
Therapeutic Procedures And Supporti...	426 (.54%)
Skin Appendage Conditions	417 (.53%)
Metabolic, Nutritional And Blood Ga...	393 (.5%)
Lower Respiratory Tract Disorders	387 (.49%)
Lifestyle Issues	386 (.49%)
Cranial Nerve Disorders	338 (.43%)
Adrenal Gland	335 (.43%)
Viral Infectious	315 (.4%)
Coronary Artery	312 (.4%)
Bone And Joint Injuries	304 (.39%)
Urinary Tract Signs	296 (.38%)
Angiedema And Urticaria	282 (.36%)
Body Temperature Conditions	281 (.36%)
Appetite And General Nutritional	273 (.35%)
Mental Impairment	271 (.34%)
Mood Disorders	263 (.33%)
Ocular Infections, Irritations And ...	253 (.32%)
Central Nervous System Vascular	243 (.31%)
Personality Disorders	222 (.28%)
Chemical Injury And Poisoning	220 (.28%)
Depressed Mood Disorders	219 (.28%)
Electrolyte And Fluid Balance Condi...	219 (.28%)
Seizures	208 (.26%)
Respiratory And Pulmonary Investiga...	198 (.25%)
Vascular Hypertensive	187 (.24%)
Hematology Investigations	184 (.23%)
Ocular Structural Change, Deposit A...	184 (.23%)
Bacterial Infectious	183 (.23%)
Heart Failures	180 (.23%)
Glucose Metabolism Disorders	176 (.22%)
Endocrine Investigations	170 (.22%)
Glaucoma And Ocular Hypertension	168 (.21%)
Procedural And Device Related Injur...	165 (.21%)
Vascular	164 (.21%)
Decreased And Nonspecific Blood Pre...	161 (.2%)
Deliria	153 (.19%)
Respiratory And Mediastinal Neoplas...	147 (.19%)
Aural	139 (.18%)
Gastrointestinal Conditions	133 (.17%)
Psychiatric	130 (.17%)
Neurological, Special Senses And Ps...	116 (.15%)
Hearing	113 (.14%)
Renal Disorders	111 (.14%)
Tissue	110 (.14%)
Inner Ear And Viiith Cranial Nerve	103 (.13%)
Disturbances In Thinking	101 (.13%)
Water, Electrolyte And Mineral	101 (.13%)
Changes In Physical Activity	98 (.12%)
Cornification And Dystrophic Skin	95 (.12%)
Hepatic And Hepatobiliary	95 (.12%)
Hepatobiliary	94 (.12%)
Miscellaneous And Site Unspecified ...	90 (.11%)
Ocular Neuromuscular	88 (.11%)
Skin Vascular Abnormalities	88 (.11%)
Psychiatric And Behavioural Symptom...	85 (.11%)
Sleep Disturbances	82 (.1%)
Vascular Hemorrhagic	82 (.1%)
Suicidal And Self-injurious Behavio...	81 (.1%)
Encephalopathies	78 (.1%)
Gastrointestinal Hemorrhages	78 (.1%)
Head And Neck Therapeutic Procedure...	78 (.1%)
Toxicology And Therapeutic Drug Mon...	73 (.09%)
Pleural	71 (.09%)
Ocular Sensory Symptoms	67 (.09%)
Renal And Urinary Tract Investigati...	67 (.09%)
Musculoskeletal And Soft Tissue Inv...	66 (.08%)
Embolism And Thrombosis	65 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Fluticasone Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Fluticasone Propionate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.